Navigation Links
Breast Cancer Patients Often Confused by Genomic Testing
Date:3/8/2010

Doctors should do more to explain test results, researchers find

MONDAY, March 8 (HealthDay News) -- Doctors need to do a better job of explaining genomic test results to breast cancer patients, say U.S. researchers.

Genomic testing -- which analyzes 21 genes in breast tumors removed during surgery in order to predict the risk of cancer recurrence -- can help guide decisions about the use of chemotherapy in patients with early-stage breast cancer. Patients at high risk may decide on more aggressive treatment, while those at low risk may opt to forego chemotherapy and its potential side effects.

For this study, researchers surveyed 77 patients with early-stage, estrogen receptor-positive breast cancer who underwent genomic testing between 2004 and 2009.

About one-third of the women said they felt they did not fully understand their discussions with doctors about their genomic test results and their risk of cancer recurrence, and about one-quarter suffered distress.

"Almost all women agreed that having the test gave them a better understanding of their treatment options chance of success," Noel Brewer, an assistant professor of health behavior and health education at the University of North Carolina's Gillings School of Public Health, said in a news release. "Most women said that they would have the test if they had to decide again today, and that they would recommend the test to other women in their same situation."

The researchers also found that most women accurately remembered the risk results from their genomic test.

While most patients in the study had a positive attitude about genomic testing and felt that it helped them better understand their treatment options, there is room for improvement in how doctors discuss cancer recurrence risk and treatment decisions with patients, Brewer and colleagues concluded.

The study is published online March 8 in the journal Cancer.

More information

The American Association for Clinical Chemistry has more about breast cancer testing.



-- Robert Preidt



SOURCE: Cancer, news release, March 8, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Survival differences by race most apparent in advanced stages of breast cancer
2. MRI finds breast cancer before it becomes dangerous
3. Pathway links inflammation, angiogenesis and breast cancer
4. Drop in breast cancer incidence linked to hormone use, not mammograms
5. Breast cancer prevention practices vary across Canada
6. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
7. Acrylamide Wont Raise Breast Cancer Risk
8. New link between estrogen and breast cancer
9. Hypnosis Eases Pain of Breast Cancer Surgery
10. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
11. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... Utah (PRWEB) , ... February 28, 2017 , ... ... held Overl.ai Inc., a healthcare automation intelligence company based in New York. , ... is ensuring the provider’s workflow remains unaltered. Those two fundamental reasons are the ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... and overall body strength, which often leads to a host of health issues, ... of the American Geriatrics Society discovered that good overall muscle strength in ...
(Date:2/27/2017)... ... February 27, 2017 , ... The threat of nuclear ... work for a company involved in the underground testing of nuclear weapons. Years later, ... Answers: Expendable Workers of the Cold War Nuclear Testing,” Clayton exposes the critical decisions ...
(Date:2/27/2017)... , ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. ... has disclosed that despite scientific studies, the Center for Disease Control ( CDC ) ... disease . Kenneth B. Liegner, M.D. has compiled into a single volume a ...
(Date:2/27/2017)... Morristown, New Jersey (PRWEB) , ... February 27, 2017 , ... ... the highest cancer rates, among all types and genders. And the need for advanced ... led by RWJ and its top-rated cancer care program, in collaboration with their non-profit ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... 28, 2017 ... Research and Markets has announced the ... 2025" report to their offering. The global ... of USD 239.8 billion by 2025. The rising prevalence of lifestyle-induced ... over the forecast period. Advancements in recombinant molecular technologies and high ...
(Date:2/28/2017)... , Feb. 28, 2017  Rigel Pharmaceuticals, Inc. ... it will report its fourth quarter and year ... March 7, 2017.  Rigel senior management will follow ... webcast at 5:00pm Eastern Time (2:00pm Pacific Time) ... can access the live conference call by dialing ...
(Date:2/28/2017)... SOUTH SAN FRANCISCO, Calif. , Feb. 27, ... company developing proprietary therapeutics for the treatment of ... drug delivery platform, today announced that the U.S. ... initial review of the ropinirole implant Investigational New ... hold the initiation of the clinical study pending ...
Breaking Medicine Technology: